HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Jin Selected Research

SY0916

1/2019Degradation Characteristics of a Novel PAF Receptor Antagonist, SY0916, in Aqueous Solution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Jin Research Topics

Disease

42Neoplasms (Cancer)
01/2021 - 01/2006
24Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 01/2006
8Adenocarcinoma of Lung
01/2022 - 12/2010
8Inflammation (Inflammations)
11/2021 - 11/2009
8Lung Neoplasms (Lung Cancer)
07/2018 - 01/2006
7Fibrosis (Cirrhosis)
12/2021 - 08/2005
7Epilepsy (Aura)
10/2021 - 11/2016
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 11/2009
7Infections
05/2019 - 06/2008
6Neoplasm Metastasis (Metastasis)
01/2021 - 01/2010
6Stomach Neoplasms (Stomach Cancer)
01/2018 - 01/2013
5Hepatitis B
06/2022 - 03/2006
5Acute Promyelocytic Leukemia
06/2021 - 04/2006
5Vomiting
11/2020 - 07/2007
5Carcinogenesis
11/2018 - 04/2008
4Sepsis (Septicemia)
07/2022 - 09/2010
4Stroke (Strokes)
02/2022 - 01/2017
4Peritoneal Fibrosis
12/2021 - 01/2019
4Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2013
4Rheumatoid Arthritis
07/2020 - 01/2015
4Disease Progression
01/2020 - 06/2008
4Nausea
11/2017 - 07/2007
4Adenocarcinoma
11/2016 - 03/2014
3Fever (Fevers)
09/2021 - 03/2015
3Prostatic Neoplasms (Prostate Cancer)
02/2021 - 01/2017
3Hemorrhage
11/2020 - 09/2010
3Ischemic Stroke
01/2019 - 03/2011
3Carcinoma (Carcinomatosis)
11/2018 - 12/2010
3Heart Failure
01/2018 - 03/2010
3Acute Kidney Injury (Acute Renal Failure)
11/2017 - 01/2015
3Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
01/2017 - 01/2008
3Necrosis
06/2014 - 05/2006
3Shock
02/2012 - 11/2010
2Insulin Resistance
06/2022 - 10/2012
2Non-alcoholic Fatty Liver Disease
06/2022 - 06/2011
2Dizziness (Lightheadedness)
02/2022 - 11/2017
2Fatty Liver
11/2021 - 05/2013
2Adenoma (Adenomas)
10/2021 - 12/2015
2Atrophy
01/2021 - 04/2011
2Parkinson Disease (Parkinson's Disease)
01/2021 - 07/2015
2Chronic Renal Insufficiency
01/2021 - 05/2018
2Pheochromocytoma
11/2020 - 01/2017
2Arthritis (Polyarthritis)
07/2020 - 01/2015
2Hepatitis
05/2020 - 09/2006
2Liver Cirrhosis (Hepatic Cirrhosis)
03/2020 - 08/2005
2Ascites
03/2020 - 01/2015
2Breast Neoplasms (Breast Cancer)
01/2020 - 08/2011
2Seizures (Absence Seizure)
01/2020 - 02/2016
2Pneumonia (Pneumonitis)
01/2020 - 05/2019
2Hypoxia (Hypoxemia)
01/2020 - 02/2016
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 06/2012

Drug/Important Bio-Agent (IBA)

10ErbB Receptors (EGF Receptor)IBA
07/2019 - 06/2011
10Tyrosine Kinase InhibitorsIBA
07/2019 - 08/2014
9Proteins (Proteins, Gene)FDA Link
06/2022 - 04/2008
9Pharmaceutical PreparationsIBA
03/2022 - 11/2009
7CytokinesIBA
07/2022 - 06/2008
7Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2010
6Biological ProductsIBA
07/2022 - 07/2015
6MicroRNAs (MicroRNA)IBA
07/2022 - 05/2013
6Glucose (Dextrose)FDA LinkGeneric
12/2021 - 06/2011
6Carcinoembryonic AntigenIBA
11/2018 - 01/2006
5RNA (Ribonucleic Acid)IBA
01/2021 - 05/2007
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 05/2006
5CollagenIBA
01/2020 - 04/2007
5Long Noncoding RNAIBA
01/2019 - 09/2014
5EnzymesIBA
07/2016 - 08/2005
4CreatinineIBA
11/2020 - 10/2012
4Paclitaxel (Taxol)FDA LinkGeneric
11/2017 - 11/2011
3AntigensIBA
09/2021 - 06/2009
3Chelating AgentsIBA
01/2021 - 01/2017
3BilirubinIBA
11/2020 - 01/2017
3AlbuminsIBA
11/2020 - 03/2013
3Arsenic Trioxide (Trisenox)FDA Link
02/2020 - 09/2006
3SolutionsIBA
01/2020 - 05/2007
3Fibronectins (Fibronectin)IBA
01/2019 - 01/2015
3LipidsIBA
01/2019 - 05/2006
3Cisplatin (Platino)FDA LinkGeneric
11/2017 - 03/2008
3CholesterolIBA
01/2017 - 06/2011
3PlatinumIBA
09/2016 - 12/2010
3CalciumIBA
07/2015 - 02/2004
3Triglycerides (Triacylglycerol)IBA
05/2013 - 06/2011
3Explosive Agents (Explosives)IBA
02/2012 - 11/2010
2Transcription Factors (Transcription Factor)IBA
06/2022 - 11/2017
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2021 - 05/2013
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2021 - 08/2011
2Amphotericin B (Amphotericin)FDA LinkGeneric
09/2021 - 09/2006
2Immune Checkpoint InhibitorsIBA
08/2021 - 01/2020
2LigandsIBA
01/2021 - 02/2015
2Hemoglobins (Hemoglobin)IBA
03/2020 - 01/2008
2Interleukin-10 (Interleukin 10)IBA
01/2020 - 06/2008
2Valsartan (Vals)FDA Link
01/2020 - 05/2013
2Therapeutic UsesIBA
01/2020 - 01/2013
2Oxygen (Dioxygen)IBA
01/2020 - 01/2019

Therapy/Procedure

25Therapeutics
07/2022 - 09/2006
21Drug Therapy (Chemotherapy)
01/2021 - 07/2007
5Immunotherapy
01/2021 - 01/2006
5Adjuvant Chemotherapy
01/2018 - 04/2011
4Peritoneal Dialysis
12/2021 - 01/2018
4Gastrectomy
06/2016 - 01/2013
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2020